Vancouver, British Columbia – TheNewswire – October 16, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) has responded through their joint venture Plasm Pharmaceutical (“Plasm”) to Health Canada’s Information Request Notice (“IRN”). The questions as posed by Health Canada are considered a formality as Plasm Pharmaceutical, continues to prepare for aContinue reading “Naturally Splendid Responds to Health Canada’s Information Request Notice”
Tag Archives: Phase 2 clinical trials
Naturally Splendid Announces LOI for Joint Venture with Biologic Pharmamedical Research for COVID 19 Clinical Trial
Vancouver, British Columbia – TheNewswire – May 19, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that it has entered into a Letter of Intent with Vancouver based Biologic Pharmamedical Research (“Biologic”) to form a joint venture for the purpose of further developing and pursuing phase 2 clinical studies,Continue reading “Naturally Splendid Announces LOI for Joint Venture with Biologic Pharmamedical Research for COVID 19 Clinical Trial”
